Skip to main content

Table 3 Direct costs associated with NSIs

From: Economic benefits of safety-engineered sharp devices in Belgium - a budget impact model

Direct costs of NSIs

 

Testing for blood-borne viruses [6, 26–30] in:

 

  NSI recipient – initial test

€38.76

  NSI recipient – follow-up test

€58.52

  Source patient (if known)

€43.91

Cost of staffing and administration per NSI [26, 31]

€68.81

Cost of PEP for hepatitis B and HIV [19, 25, 32, 33] per:

 

  NSI from a known and infected source

€374.61

  NSI from an unknown source

€918.76

Cost of treatment of blood-borne viruses [19, 25, 34–38]:

€2,377.44

  Hepatitis B (year in which NSI occurred and per subsequent year for three years)

 

  Hepatitis C (year in which NSI occurred only)

€16,127.76

  HIV (year in which NSI occurred and per subsequent year)

€16,999.83